Looking forward to a third bidder *cough* Shell *cough* entering the fray. $0.86 was definitely undervalued. Given Infigen has already made some tentative steps into the retail side of things with an attractive PPA offering, their growth potential was a big drawcard for me to become a shareholder - it would be a real shame to see it sold below its worth because the board are stuck thinking short-term..
Looking forward to a third bidder *cough* Shell *cough* entering...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)